[1] |
Leukemia and Lymphoma Group, Society of Hematology, Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of eosinophilia(2017)[J]. Chin J Hematol, 2017, 38(7): 561-565. DOI: 10.3760/cma.j.issn.0253-2727.2017.07.001.
中华医学会血液学分会白血病淋巴瘤学组. 嗜酸粒细胞增多症诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志, 2017, 38(7): 561-565. Doi: 10.3760/cma.j.issn.0253-2727.2017.07.001.
|
[2] |
LAMMEL V, STOECKLE C, PADBERG B, et al. Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung[J]. Lung Cancer, 2012, 76(3): 493-495. DOI: 10.1016/j.lungcan.2012.02.014.
|
[3] |
PANDIT R, SCHOLNIK A, WULFEKUHLER L, et al. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome[J]. Am J Hematol, 2007, 82(3): 234-237. DOI: 10.1002/ajh.20789.
|
[4] |
MATSUMOTO N, YOKOYAMA K, NAKAI K, et al. A case of eosinophilic cholangitis: Imaging findings of contrast-enhanced ultrasonography, cholangioscopy, and intraductal ultrasonography[J]. World J Gastroenterol, 2007, 13(13): 1995-1997. DOI: 10.3748/wjg.v13.i13.1995.
|
[5] |
LI L, LIU H, SONG WY. Clinical features, diagnosis, and treatment of IgG4-associated sclerosing cholangitis[J]. J Clin Hepatol, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.
李丽, 刘辉, 宋文艳, IgG4相关硬化性胆管炎临床特征及诊疗过程分析[J]. 临床肝胆病杂志, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.
|
[6] |
AHYI AN, CHANG HC, DENT AL, et al. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines[J]. J Immunol, 2009, 183(3): 1598-1606. DOI: 10.4049/jimmunol.0803302.
|
[7] |
de ROZA MA, LIM CH. Eosinophilic cholangitis treatment with budesonide[J]. World J Hepatol, 2017, 9(36): 1385-1388. DOI: 10.4254/wjh.v9.i36.1385.
|